$ISRG +0.88% Moves Higher as 20% APAC Procedure Growth Supports the Outlook
$Intuitive Surgical(ISRG)$
$Intuitive Surgical (ISRG) Edges +0.88% to $353.24: Momentum Divergence Nears Climax, $357.99 Breakout Could Trigger Short Squeeze
Latest Close Data: ISRG closed at $353.24 (+0.88%) on 2026-09-10, near the day's high of $357.99. Price remains 41.5% below the 52-week high of $603.88, but is trading just 7.5% above the 52-week low of $328.57.
Core Market Drivers: Surgical robotics leader facing sector-wide pressure as healthcare equipment peers slid earlier this week. Company announced a 316K sq ft Malaysia manufacturing facility (operational 2028) to capture APAC demand, where Q2 procedure volumes grew 20%. Q2 EPS of $2.80 beat consensus by 12%, but full-year procedure guidance was maintained, sparking post-earnings selling.
Technical Analysis: Volume of 2.42M shares with Volume Ratio of 1.11 signals mild accumulation. MACD remains deeply negative (DIF -6.01, DEA -3.51, histogram -5.01) but downside momentum is decelerating. RSI(6) rebounded to 27.17 from oversold 20.06, while RSI(12) sits at 35.77 — still bearish but recovering. KDJ shows K(16.73) below D(19.06), confirming weak near-term structure.
Key Price Levels:
-
Primary Support: $340.97 (recent swing low)
-
Strong Resistance: $431.67 (September 8 high)
-
Immediate Pivot: $357.99 (today's high) — a close above this reopens $380 zone
Valuation Perspective: Forward P/E of 32.49 sits well below the historical average of 58.93 and the -1 Std.Dev of 46.39, indicating the market has aggressively de-rated ISRG. TTM P/E of 40.51 and P/S of 11.35 remain elevated for medtech but are at multi-year compression.
Analyst Targets: 29 institutions maintain an average target of $480.77 (range $324–$685), implying +36% upside. Breakdown: 11 Strong Buy, 13 Buy, 9 Hold, 1 Underperform.
Weekly Outlook: Expect range-bound action between $340.97 and $357.99. A decisive break above $357.99 on expanding volume targets $380–$400. A failure at $340.97 opens the door to retesting the 52-week low of $328.57. Watch for MACD histogram turning positive as early reversal confirmation.
⚠️ Market data is for informational purposes only and does not constitute investment advice. Trading involves substantial risk. 📉📊
🎯 $Intuitive Surgical (ISRG) Options Strategy: Bull Call Spread (Debit Spread)
-
Underlying: ISRG (Intuitive Surgical Inc.)
-
View: Cautiously bullish — oversold bounce expected toward $357.99–$380 resistance zone; MACD downside momentum decelerating, RSI rebounding from deeply oversold levels
-
Strategy Type: Debit spread / Directional long with defined risk
-
Option Contract Portfolio:
-
Buy 1x ISRG 2026-09-18 $350 Call @ $10.55 (mid)
-
Sell 1x ISRG 2026-09-18 $365 Call @ $3.875 (mid)
-
-
Max Gain & Loss:
-
Max Gain: $833 per spread ([$365 − $350] × 100 − net debit)
-
Max Loss: $668 per spread (net debit paid)
-
-
Initial Cost/Credit: Net Debit = $6.675 per share ($667.50 per spread)
When markets keep you watching, knowing when to switch off matters too.
A strong U.S. jobs report has put rates back in focus, with this week’s CPI data set to be another key market mover — keeping overnight trading firmly on investors’ radar. But investing is a long game, and you don’t have to watch every move. The new Night Trading Dollar Eye Mask is soft, lightweight and comfortable, made for quick breaks between market moves, power naps or long-haul travel — so you can switch off, recharge and come back ready for what’s next.
Redeem the new Night Trading Dollar Eye Mask in Tiger Coin Mall. Keep an eye on the market — and give your eyes a break.
https://laohu8.com/J/redeemGift?goodID=100557&type=delivery
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

